US$ 23.28
uncompounded semaglutide FBI issues safety warning about counterfeit versions of weight loss drug Semaglutide for weight loss |
Description
The SUSTAIN-6 trial of over 3,000 type 2 diabetes patients found severe hypoglycemia in fewer than 1% taking semaglutide monotherapy, compared to 1020% on older insulin-forcing drugs

doi: 10.1123/jpah.2012-0250

Nevertheless, concerns remain about complications in this group of patients who often pose very high surgical risk

Diabetes Ther 15: 497-519

Advert The drug then stabilises blood sugar and curbs cravings, making you feel fuller for longer

References Esatbeyoglu, T
